AK-0406

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameAK-0406
Drug Alias NameAK-0406AK0406
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Drug-Fc conjugate
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Ark Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesArk Biosciences Pty LtdShanghai Ark Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A